Navigation Links
Aida Receives Chinese Government Innovation Award
Date:1/7/2008

SANTA MONICA, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced that it has received an award from the Science and Technology Department of Zhejiang Province, one of the richest regions in China and known throughout the country for its focus on innovation. Aida was rewarded by the governmental authority because of its "clinical research and commercialization of Rh-Apo2L" as a "significant scientific and social developing project" recognized by the Science and Technology Department of Zhejiang Province. The Science and Technology Department of Zhejiang Province is the governmental administrative department for the entire science and technology industry in Zhejiang Province.

Mr. Jin Biao, Chairman of Aida Pharmaceuticals, stated, "We are very honored to have this major award bestowed on us by the Science and Technology Department of Zheijiang Province. The government has supported our efforts throughout Rh-Apo2L's development process." The award also includes a financial reward, totaling RMB1.2 million (US$164,982.47, as of January 2008).

About Aida Pharmaceuticals

Aida Pharmaceuticals is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. The Company has nine product lines including its main product, Etimicin Sulfate, the first antibiotic developed in China, which it manufactures and markets in powder, liquid and transfusion form. Aida Pharmaceuticals, in operation since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP certified in China and ISO9002 certified for quality assurance and ISO14000 certified for ecologically-friendly practices.
'/>"/>

SOURCE Aida Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Three Palm Software Receives FDA 510(k) Clearance for Its WorkstationOne(TM) Breast Imaging Workstation
2. Genta Receives NASDAQ Non-Compliance Notice
3. Tapestry Receives Notice Regarding Minimum Bid Price Rule
4. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
5. Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
6. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
7. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
8. Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
9. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
11. Healthcare Technologies, Ltd. Receives Notice From Nasdaq
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...
(Date:12/16/2009)... ultimate CHO cell culture supplement? InVitria has what scientists have ... media supplement that improves the growth and productivity of CHO ... Zap-CHO is an animal free, well defined and consistent recombinant ... ... CO (PRWEB) December 16, 2009 -- Scientists working with CHO ...
(Date:12/16/2009)... and Separations Society will hold its 23rd Annual Technical Conference & ... San Antonio, Texas. To further impact the separation society and reach ... to announce that the 2010 AFS Annual Technical Conference will be ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- The American ...
(Date:12/15/2009)... WALTHAM, Mass., Dec. 15 Repligen Corporation ... Company has received $731,000 in research funding to ... Friedreich,s ataxia from the Muscular Dystrophy Association (MDA). ... preclinical GLP toxicology testing and GMP manufacture of ... Support from the MDA not only provides important ...
Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... announced today that the Company will host an investor ... PM Eastern Time to present an,analysis of the data ... IT-R-006) for the treatment of nasolabial folds, or,wrinkles. On ... results from these two studies, which met all primary ...
... benefits of ACTEMRA for rheumatoid,arthritis -, NUTLEY, ... a,total of 15 abstracts involving its investigational rheumatoid ... presentation,at the 2008 American College of Rheumatology (ACR) ... in San Francisco. These,studies evaluate ACTEMRA, a novel ...
... Ventures for Global Health to Work with Industry ... BIO Ventures for Global,Health (BVGH) today announced ... (FDA) release of Draft Guidance for Industry on ... is designed to,encourage industry investment in the development ...
Other Biology Technology:Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies 2ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 2ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 3ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 4FDA Issues Draft Guidance on Priority Review Vouchers 2
(Date:12/16/2009)... DC US Secretary of Energy Steven Chu announced ... for their outstanding contributions in research and development supporting ... six winners named today will receive a gold medal, ... honored at a ceremony in Washington, DC early next ... the national, economic and energy security of the United ...
(Date:12/16/2009)... get psyched up for contests, but when these rituals ... down before and during events, they could be causing ... for the symptoms of an injury, not the injury ... focuses on musculoskeletal health and sports medicine. "They may ... certain level, but pain occurs for a reason. It ...
(Date:12/16/2009)... Medicine researcher will lead the coordinating center for a ... field of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., ... the National Heart, Lung and Blood Institute (NHLBI) to ... which will be called the NHLBI Progenitor Cell Biology ... $30 million grant over seven years. , ...
Breaking Biology News(10 mins):Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2NSAIDs: Take 'em early and often when competing? Think again 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 1Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 2Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 3Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 4Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 5Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 6Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 7Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 8Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 9Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 10Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 11Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 12Par Pharmaceutical Reports EPS of 240 71 for Second Quarter 2009 53593 13ETC Biomedical Announces Chamber Sale in India 13344 1ETC Biomedical Announces Chamber Sale in India 13344 2ETC Biomedical Announces Chamber Sale in India 13344 3ETC Biomedical Announces Chamber Sale in India 13344 4OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 1OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 2OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor Logos Technologies Ltd 13341 3
... at Washington University in St. Louis and Arizona State University have ... by making an even rarer form of chlorophyll, chlorophyll d. Chlorophyll ... to the naked eye. , ... with virtually no other plant or bacterium in the world for ...
... of the most important metabolic processes in our bodies, ... intermediates have been produced in multigram quantitieswith one exception, ... University of Leipzig have finally done it. As they ... combination of one biotechnological and one chemical step, starts ...
... with diabetes, cardiac problems, kidney disorders or high blood ... technology. The new "smart" holograms, which can detect ... much simpler, cheaper and more reliable, write Chris Lowe ... hologram is a recording of an optical interference pattern ...
Other Biology News:Bacterium sequenced makes rare form of chlorophyll 2Bacterium sequenced makes rare form of chlorophyll 3Kilogram quantities at last! 2'Smart' holograms help patients help themselves 2